Imodium and Nintedanib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Nintedanib (nintedanib). Common drug interactions include asthenia among females and clostridium difficile colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Nintedanib. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Nintedanib?

Nintedanib has active ingredients of nintedanib. eHealthMe is studying from 1,514 Nintedanib users. Check the latest studies of Nintedanib.

On Jul, 13, 2026

11 people who take Imodium and Nintedanib together, and have interactions are studied.

Imodium and Nintedanib drug interactions.

What are the common drug interactions of Imodium and Nintedanib, by gender? *:

female:

Asthenia (weakness)
Atrial thrombosis (blood clot that develops in an artery)
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
Headache (pain in head)
Hypertension (high blood pressure)
Interstitial lung disease
Vomiting
Chest discomfort
Choking sensation (feeling of obstruction in respiratory system)
Cough

male:

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Neck pain
Pneumonia
Cardiac arrest
Constipation

What are the common drug interactions of Imodium and Nintedanib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Atrial thrombosis (blood clot that develops in an artery)
Headache (pain in head)
Hypertension (high blood pressure)
Vomiting

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection)
Blindness unilateral
Pneumonia
Cardiac arrest
Chest discomfort
Choking sensation (feeling of obstruction in respiratory system)
Constipation
Cough
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

Systemic Sclerosis Pulmonary (an autoimmune or connective tissue disease. it is characterized by thickening of the skin with involvement of lungs): 3 people, 27.27%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 27.27%
Upper Respiratory Tract Infection: 3 people, 27.27%
Weight Decreased: 2 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 18.18%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 18.18%
Interstitial Lung Disease: 2 people, 18.18%
Indigestion: 1 person, 9.09%
Depression: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Nintedanib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously